Published in Mental Health Business Week, April 24th, 2004
The report, entitled "Neurology Pipeline Analysis: Top Companies Maintain Position Through 2007," notes that Pfizer has a drug in each neurology category discussed - Alzheimer disease, Parkinson disease, multiple sclerosis, and epilepsy.
"Although Pfizer will remain the leader in the neurological drug market in 2007, Johnson & Johnson (J&J) and Novartis will also become key players in this therapeutic area, capturing 12% and 11% of the market, respectively, said Heather Martin, analyst at Decision Resources.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.